4
Changes in Ownership
IDEAYA Biosciences, Inc. Filed Acc 0001610717-23-000258
Chief Legal Officer sold 3,837 shares at an average $30.03 ($115,222)
- Chief Legal Officer acquired 3,837 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Throne Jason · Chief Legal Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,100 | $12.86 | $27,006 | 2,100 | D |
| 2023-09-01 | Sale : show line 2 in the form 10b5-1 | −2,100 | $30.03 | $63,063 | 0 | D |
| 2023-09-05 | Exercise or conversion : show line 3 in the form 10b5-1 | +1,737 | $12.86 | $22,338 | 1,737 | D |
| 2023-09-05 | Sale : show line 4 in the form 10b5-1 | −1,737 | $30.03 | $52,160 | 0 | D |
| Open-market sales · 3,837 sh · avg $30.03 · $115,222 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-09-01 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −2,100 | 56,650 | D |
| 2023-09-05 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −1,737 | 54,913 | D |
Loading xslF345X05/form4.xml…